ArticleFrontiers in oncology2025
Case Report: Pitfalls in anatomic pathology and clinical oncology: a case of misdiagnosed pulmonary Ewing sarcoma as SCLC.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulmonary Ewing Sarcoma Presenting As Chronic Cough.Cureus · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In oncology, an accurate pathological diagnosis can often mean the difference between cure and failure, potentially determining a patient's survival. We present the case of a 28-year-old, never-smoking man whose initial diagnosis of small cell lung cancer (SCLC) was confirmed by the anatomic pathology laboratory upon reevaluation, despite initial doubt. This misclassification ultimately led to therapeutic failure following an initial complete remission and likely contributed to the poor outcome after the diagnosis was later corrected to pulmonary Ewing sarcoma. Primary pulmonary Ewing sarcoma is a rare malignancy that is often overlooked in adults. This case underscores not only the striking clinical and histopathological overlap between SCLC and pulmonary Ewing sarcoma but also the potentially fatal consequences of missing key diagnostic red flags, including the patient's young age, non-smoking status, and atypical clinical course. Through this patient's journey, we emphasize the importance of multidisciplinary collaboration, the limitations of relying solely on immunohistochemistry, and the critical role of early molecular testing. This case serves as a stark reminder that behind every pathology report is a human life-one that depends on the vigilance, humility, and thoroughness of the medical team entrusted with their care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.